Get Started

ANNX

NASD Annexon, Inc.
Oct 29, 2026 · 12:42 AM ET EOD Market Closed

$4.04 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.04, $0.01 below the day’s high of $4.05

YTD change
-19.52%
vs 20-day SMA
+3.60%
vs 200-day SMA
-23.07%

Price ranges

Previous day
$3.68 $3.84
open $3.72 close $3.76
+$0.04 (+1.08%)
Today
$3.72 $4.05
open $3.78 now $4.04
+$0.26 (+6.88%)
Past week
$3.64 $4.07
from $3.83 now $4.04
+$0.21 (+5.48%)
Past month
$3.36 $4.38
from $4.13 now $4.04
-$0.09 (-2.18%)
This year
$3.36 $7.18
from $5.02 now $4.04
-$0.98 (-19.52%)

Price & Performance

-1.96 (-32.67%) / 6M

$3.16$4.36$5.55$6.75Apr 28Jul 29Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 89.4% away from all-time highs of $38.01
  • ANNX is down 20% since the beginning of the year
  • ANNX is up 17% over the past 12 months
  • ANNX is down 2% over the past 1 month
  • 17% of all ANNX investors are betting against ANNX

ANNX reads very good: price sits above one of the two key moving averages, the 12-month move is +17.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.28
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $571.2M
Beta 2.24

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$209.2M
Debt$24.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $825.9M

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $451.83 +0.87%
MRNA Moderna, Inc. $214.17 +2.98%
RVMD Revolution Medicines, Inc. $188.72 +1.34%
ROIV Roivant Sciences Ltd. $37.11 +1.56%
BNTX BioNTech SE Sponsored ADR $87.99 +1.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.